Significance of connective tissue disease features in idiopathic interstitial pneumonia

被引:140
作者
Corte, T. J. [2 ,6 ,7 ]
Copley, S. J. [2 ,3 ]
Desai, S. R. [2 ,4 ]
Zappala, C. J. [2 ,8 ]
Hansell, D. M. [2 ,5 ]
Nicholson, A. G. [2 ,5 ]
Colby, T. V. [2 ,9 ]
Renzoni, E. [2 ,5 ]
Maher, T. M. [2 ,5 ]
Wells, A. U. [1 ,2 ,5 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Interstitial Lung Dis Unit, Dept Resp Med, London SW3 6LP, England
[2] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LP, England
[3] Imperial NHS Trust, Hammersmith Hosp, Dept Radiol, London, England
[4] Kings Coll Hosp Fdn NHS Trust, Dept Radiol, London, England
[5] Univ London Imperial Coll Sci Technol & Med, Dept Resp Med, London SW3 6LP, England
[6] Univ Sydney, Dept Resp Med, Sydney, NSW 2006, Australia
[7] Royal Prince Alfred Hosp, Dept Resp Med, Sydney, NSW, Australia
[8] Royal Brisbane Hosp, Dept Resp Med, Brisbane, Qld 4029, Australia
[9] Mayo Clin, Dept Histopathol, Scottsdale, AZ USA
关键词
Connective tissue disease; idiopathic interstitial pneumonia; idiopathic pulmonary fibrosis; nonspecific interstitial pneumonia; prognosis; undifferentiated connective tissue disease; 5-YEAR FOLLOW-UP; PULMONARY-FIBROSIS; HISTOPATHOLOGIC SUBSETS; PROGNOSTIC-SIGNIFICANCE; ANTINUCLEAR ANTIBODIES; HISTOLOGIC PATTERN; LUNG-DISEASE; STANDARDIZATION; MANIFESTATION; CLASSIFICATION;
D O I
10.1183/09031936.00174910
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
In idiopathic interstitial pneumonia (IIP), the significance of connective tissue disease (CTD) features in the absence of a specific CTD diagnosis remains unclear. We studied the clinical and prognostic utility of a diagnosis of undifferentiated CTD (UCTD) in patients with biopsy-proven IIP. IIP patients undergoing surgical lung biopsy (1979-2005) were studied (nonspecific interstitial pneumonia (NSIP), n=45; idiopathic pulmonary fibrosis, n=56). UCTD was considered present when serum autoantibodies were present and symptoms or signs suggested CTD. The relationship between UCTD and NSIP histology was evaluated. A clinical algorithm that best predicted NSIP histology was constructed using a priori variables. The prognostic utility of UCTD, and of this algorithm, was evaluated. UCTD was present in 14 (31%) NSIP and seven (13%) IPF patients. UCTD was not associated with a survival benefit. The algorithm predictive of NSIP (OR 10.4, 95% CI 3.21-33.67; p < 0.0001) consisted of the absence of typical high-resolution computed tomography (HRCT) features for IPF and 1) a compatible demographic profile (females aged < 50 yrs) or 2) Raynaud's phenomenon. In patients with an HRCT scan not typical for IPF, this algorithm predicted improved survival (hazard ratio 0.35, 95% CI 0.14-0.85; p=0.02) independent of IIP severity. UCTD is associated with NSIP histology. However, the diagnostic and prognostic significance of UCTD in IIP patients remains unclear.
引用
收藏
页码:661 / 668
页数:8
相关论文
共 51 条
[1]  
ALARCON GS, 1991, J RHEUMATOL, V18, P1332
[2]  
Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646
[3]  
[Anonymous], 2002, Am J Respir Crit Care Med, V165, P277304, DOI [10.1164/ajrccm.165.2.ats01, DOI 10.1164/AJRCCM.165.2.ATS01]
[4]   Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis [J].
Bjoraker, JA ;
Ryu, JH ;
Edwin, MK ;
Myers, JL ;
Tazelaar, HD ;
Schroeder, DR ;
Offord, KP .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (01) :199-203
[5]   Osteoporosis in mixed connective tissue disease [J].
Bodolay, E ;
Bettembuk, P ;
Balogh, A ;
Szekanecz, Z .
CLINICAL RHEUMATOLOGY, 2003, 22 (03) :213-217
[6]  
Bodolay E, 2003, CLIN EXP RHEUMATOL, V21, P313
[7]   Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome [J].
Bouros, D ;
Wells, AU ;
Nicholson, AG ;
Colby, TV ;
Polychronopoulos, V ;
Pantelidis, P ;
Haslam, PL ;
Vassilakis, DA ;
Black, CM ;
du Bois, RM .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (12) :1581-1586
[8]  
Cavazzana I, 2001, CLIN EXP RHEUMATOL, V19, P403
[9]  
CLEGG DO, 1991, J RHEUMATOL, V18, P1340
[10]  
Danieli MG, 1999, CLIN EXP RHEUMATOL, V17, P585